MS
SYNH

Maven Securities’s Syneos Health, Inc. Class A Common Stock SYNH Stock Holding History

Maven Securities’s Portfolio SYNH Stock Details SYNH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-50,000
Closed -$4.44M – 1342
2021
Q2 		$4.44M Buy
+50,000
New +$4.22M 0.18% 99
2020
Q4 		– Sell
-122,678
Closed -$6.55M – 916
2020
Q3 		$6.55M Buy
+122,678
New +$7.3M 0.54% 38

Other funds holding SYNH

Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Mackenzie Financial
Mackenzie Financial Toronto Ontario, Ontario, Canada $83.3B AUM 31.19% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

Maven Securities's SYNH Position: Q3 2021 in Review

Maven Securities sold out of Syneos Health, Inc. Class A Common Stock (SYNH) in Q3 2021, closing a stake of 50,000 shares — an estimated $4.44M sold.

Maven Securities first reported a position in SYNH in Q3 2020 and held it in 2 quarters. The position peaked at $6.55M in Q3 2020. 355 funds tracked by Wall St. Rank hold SYNH as of Q3 2021.

  • Maven Securities reported no remaining Syneos Health, Inc. Class A Common Stock position as of Q3 2021 after selling out during the quarter.
  • Maven Securities sold 50,000 Syneos Health, Inc. Class A Common Stock shares in Q3 2021, an estimated $4.44M.
  • Maven Securities first reported a position in Syneos Health, Inc. Class A Common Stock in Q3 2020 and held it in 2 quarters.
  • Maven Securities's Syneos Health, Inc. Class A Common Stock position peaked at $6.55M in Q3 2020.
  • 355 funds tracked by Wall St. Rank held Syneos Health, Inc. Class A Common Stock as of Q3 2021.

Based on Maven Securities's 13F filing for Q3 2021, filed 15 Nov 2021.